Organigram Q3 Revenue Increases 20% Sequentially to C$38.1 Million
Organigram Reports Third Quarter Fiscal 2022 Results. Achieves fourth consecutive quarter of record net revenue and continues growth as a leading Canadian LP... #OGI #Organigram #OrganigramHoldings
United States New Brunswick Strategic Investment In Hyasynth Biologicals Inc International Financial Reporting Standards Infusions Corporation Centre Of Excellence Co
Source: newcannabisventures.com